TherapeuticsMD | TXMD - Ebitda

Stock Price
2.33
Daily Change
0.04 1.53%
Monthly
2.88%
Yearly
130.20%
Q1 Forecast
2.17

TherapeuticsMD reported $-1.64M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 3.13B 1.17B Dec/2025
Grifols EUR 482.04M 7.04M Sep/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Pfizer USD 6.08B 351M Sep/2025
TherapeuticsMD USD -1.64M 700K Sep/2023